Rothschild & Co Asset Management US’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,849
Closed -$595K 323
2020
Q3
$595K Sell
7,849
-110,378
-93% -$8.2M 0.01% 289
2020
Q2
$8.63M Sell
118,227
-612
-0.5% -$39.2K 0.13% 227
2020
Q1
$5.72M Sell
118,839
-7,842
-6% -$504K 0.09% 246
2019
Q4
$9.91M Buy
126,681
+4,864
+4% +$342K 0.1% 253
2019
Q3
$7.57M Buy
121,817
+97,608
+403% +$6.5M 0.08% 266
2019
Q2
$1.8M Hold
24,209
0.02% 309
2019
Q1
$1.6M Sell
24,209
-12
-0% -$770 0.02% 315
2018
Q4
$1.38M Sell
24,221
-156
-0.6% -$9.62K 0.02% 340
2018
Q3
$1.76M Buy
+24,377
New +$1.96M 0.02% 340
2015
Q4
Sell
-22,394
Closed -$1.24M 531
2015
Q3
$1.24M Buy
+22,394
New +$1.35M 0.02% 320
2013
Q3
Sell
-37,413
Closed -$2.1M 395
2013
Q2
$2.1M Buy
+37,413
New +$1.96M 0.05% 332

Other funds holding MGLN

Rothschild & Co Asset Management US's MGLN Position: Q4 2020 in Review

Rothschild & Co Asset Management US sold out of Magellan Health Services, Inc. (MGLN) in Q4 2020, closing a stake of 7,849 shares — an estimated $595K sold.

Rothschild & Co Asset Management US first reported a position in MGLN in Q2 2013 and held it in 11 quarters. The position peaked at $9.91M in Q4 2019. 191 funds tracked by Wall St. Rank hold MGLN as of Q4 2020.

  • Rothschild & Co Asset Management US reported no remaining Magellan Health Services, Inc. position as of Q4 2020 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 7,849 Magellan Health Services, Inc. shares in Q4 2020, an estimated $595K.
  • Rothschild & Co Asset Management US first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 11 quarters.
  • Rothschild & Co Asset Management US's Magellan Health Services, Inc. position peaked at $9.91M in Q4 2019.
  • 191 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q4 2020.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2020, filed 8 Feb 2021.